Literature DB >> 11166162

Dysferlinopathy (LGMD2B): a 23-year follow-up study of 10 patients homozygous for the same frameshifting dysferlin mutations.

I Mahjneh1, G Marconi, K Bushby, L V Anderson, H Tolvanen-Mahjneh, H Somer.   

Abstract

The limb-girdle muscular dystrophies are a group of inherited neuromuscular disorders which are clinically and genetically heterogeneous. We have been able to carry out a follow-up study on 10 patients from a large Palestinian family with a confirmed mutation in the dysferlin gene. These patients have been followed for more than 23 years since the onset of the disease. They all had normal developmental milestones. The onset of the disease was usually in the second decade, more rarely in the third and fourth decades. The first symptoms were difficulty with running and climbing stairs. Patients showed a distinct type of gait due to the unique pattern of muscle involvement which was characterised by early involvement of the posterior muscle compartment of the thighs and legs (hamstrings, adductors, gastrocnemius and soleus). The shoulder and upper limb musculature became involved later, especially supra and infraspinatus and biceps. In the early stages of disease these patients may clinically show only proximal lower limb-girdle muscle weakness; however, the use of muscle imaging techniques were very important, always detecting in these patients also distal lower limb muscle involvement, so that the pattern of muscle involvement found in dysferlin deficiency may not strictly conform to the definition of limb-girdle muscular dystrophy. The pattern of muscular dystrophy is essentially uniform and has clearly distinct features (involving mainly the initial pattern of muscle involvement and the mode of gait) which differ significantly from the well reported clinical features associated with sarcoglycanopathy, calpainopathy and Miyoshi myopathy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11166162     DOI: 10.1016/s0960-8966(00)00157-7

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  19 in total

Review 1.  Immunobiology of Inherited Muscular Dystrophies.

Authors:  James G Tidball; Steven S Welc; Michelle Wehling-Henricks
Journal:  Compr Physiol       Date:  2018-09-14       Impact factor: 9.090

2.  Novel diagnostic features of dysferlinopathies.

Authors:  Xiomara Q Rosales; Julie M Gastier-Foster; Sarah Lewis; Malik Vinod; Devon L Thrush; Caroline Astbury; Robert Pyatt; Shalini Reshmi; Zarife Sahenk; Jerry R Mendell
Journal:  Muscle Nerve       Date:  2010-07       Impact factor: 3.217

3.  Genetic ablation of complement C3 attenuates muscle pathology in dysferlin-deficient mice.

Authors:  Renzhi Han; Ellie M Frett; Jennifer R Levy; Erik P Rader; John D Lueck; Dimple Bansal; Steven A Moore; Rainer Ng; Daniel Beltrán-Valero de Bernabé; John A Faulkner; Kevin P Campbell
Journal:  J Clin Invest       Date:  2010-11-08       Impact factor: 14.808

Review 4.  Therapeutic possibilities in the autosomal recessive limb-girdle muscular dystrophies.

Authors:  Volker Straub; Kate Bushby
Journal:  Neurotherapeutics       Date:  2008-10       Impact factor: 7.620

5.  Myogenesis in dysferlin-deficient myoblasts is inhibited by an intrinsic inflammatory response.

Authors:  Tatiana V Cohen; Jonathan E Cohen; Terence A Partridge
Journal:  Neuromuscul Disord       Date:  2012-05-03       Impact factor: 4.296

6.  Diagnostic value of muscle MRI in differentiating LGMD2I from other LGMDs.

Authors:  Dirk Fischer; Maggie C Walter; Kristina Kesper; Jens A Petersen; Stefania Aurino; Vincenzo Nigro; Christian Kubisch; Thomas Meindl; Hanns Lochmüller; Kai Wilhelm; Horst Urbach; Rolf Schröder
Journal:  J Neurol       Date:  2005-02-23       Impact factor: 4.849

7.  Dysferlinopathy course and sportive activity: clues for possible treatment.

Authors:  C Angelini; E Peterle; A Gaiani; L Bortolussi; C Borsato
Journal:  Acta Myol       Date:  2011-10

8.  Heterogeneous characteristics of Korean patients with dysferlinopathy.

Authors:  Hyung Jun Park; Ji-Man Hong; Gyoung Im Suh; Ha Young Shin; Seung Min Kim; Il Nam Sunwoo; Bum Chun Suh; Young-Chul Choi
Journal:  J Korean Med Sci       Date:  2012-03-21       Impact factor: 2.153

9.  New aspects on patients affected by dysferlin deficient muscular dystrophy.

Authors:  Lars Klinge; Ahmed Aboumousa; Michelle Eagle; Judith Hudson; Anna Sarkozy; Gianluca Vita; Richard Charlton; Mark Roberts; Volker Straub; Rita Barresi; Hanns Lochmüller; Kate Bushby
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-06-14       Impact factor: 10.154

10.  Clinical features and a mutation with late onset of limb girdle muscular dystrophy 2B.

Authors:  Toshiaki Takahashi; Masashi Aoki; Naoki Suzuki; Maki Tateyama; Chikako Yaginuma; Hitomi Sato; Miho Hayasaka; Hitomi Sugawara; Mariko Ito; Emi Abe-Kondo; Naoko Shimakura; Tohru Ibi; Satoshi Kuru; Tadashi Wakayama; Gen Sobue; Naoki Fujii; Toshio Saito; Tsuyoshi Matsumura; Itaru Funakawa; Eiichiro Mukai; Toru Kawanami; Mitsuya Morita; Mineo Yamazaki; Takashi Hasegawa; Jun Shimizu; Shoji Tsuji; Shigeki Kuzuhara; Hiroyasu Tanaka; Masaru Yoshioka; Hidehiko Konno; Hiroshi Onodera; Yasuto Itoyama
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-12-15       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.